A global treatment standard in multiple myeloma (MM) remains elusive despite advances in care over 15 years: first results from INSIGHT MM, the largest global prospective, observational MM study

Authors

Caitlin L. CostelloFollow
Mario BoccadoroFollow
Michael A. Thompson, Advocate Aurora HealthFollow
et al

Recommended Citation

Costello C, Boccadoro M, Usmani SZ, Chari A, Rifkin RM, Abonour R, Berdeja J, Cook G, Goldschmidt H, Hajek R, Hungria V, Lee HC, Leleu X, Omel J, Spencer A, Thompson MA, Vela-Ojeda J, Zonder JA, Puig N, Aguarón A, Davies FE, Demers B, Ren K, Yu S, Skacel T, Stull DM, Terpos E. A global treatment standard in multiple myeloma (MM) remains elusive despite advances in care over 15 years: first results from INSIGHT MM, the largest global prospective, observational MM study. Clinical Lymphoma Myeloma Leukemia. Sep 2018;18(S1):S247-S248.

Affiliations

Aurora Cancer Center, Aurora Health Care

Presentation Notes

Abstract presented at Society of Hematologic Oncology Sixth Annual Meeting (SOHO); September 12-15, 2018; Houston, TX.

Document Type

Abstract